9920 PACIFIC HEIGHTS BLVD, SUITE 150, SAN DIEGO, CA
Reports First Quarter 2026 Financial Results and Provides a Corporate Update
Announces $50 Million Credit Facility and Royalty Transaction Extending Anticipated Cash Runway into 2028
Unaudited Pro Forma Condensed Combined Financial Information
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Announces $15.6 Million Registered Direct Offering
News, Material Contracts
TuHURA Biosciences, Inc. Registration Statement on Form S-3 Effective
Q3
Amended Annual Report
FY 2025
Q1
Q4
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(3)
Notice of Exempt Offering of Securities
Registration Statement for Securities Offered under a Shelf Registration
Effectiveness Notice
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload